Hui Quan Selected Research

1- stearoyl- 2- linoleoylphosphatidylcholine

6/2019	Stearoyl lysophosphatidylcholine inhibits LPS-induced extracellular release of HMGB1 through the G2A/calcium/CaMKKβ/AMPK pathway.
10/2016	Stearoyl lysophosphatidylcholine enhances the phagocytic ability of macrophages through the AMP-activated protein kinase/p38 mitogen activated protein kinase pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui Quan Research Topics

Disease

3	Sepsis (Septicemia) 05/2021 - 09/2015
3	Adenoma (Adenomas) 02/2007 - 03/2005
3	Ulcer 02/2007 - 08/2003
2	Wounds and Injuries (Trauma) 04/2022 - 07/2021
2	Neoplasms (Cancer) 01/2022 - 11/2018
2	Bites and Stings (Sting) 01/2018 - 03/2016
2	Polyps 02/2007 - 03/2005
2	Hemorrhage 02/2007 - 08/2003
2	Peptic Ulcer (Peptic Ulcers) 02/2007 - 01/2002
2	Osteoarthritis 08/2004 - 08/2003
1	Carcinogenesis 01/2022
1	Cognitive Dysfunction 01/2022
1	Atherosclerosis 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Abdominal Obesity 01/2022
1	Ischemic Stroke 09/2020
1	Cerebral Infarction 01/2020
1	Vascular Remodeling 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 11/2018
1	Bacterial Infections (Bacterial Infection) 10/2016
1	Acute Lung Injury 02/2016
1	Varicose Veins (Varicose Vein) 01/2015
1	Portal Hypertension 01/2015
1	Inflammation (Inflammations) 01/2015
1	Hypersplenism (Anemia, Splenic) 01/2015
1	Chronic Renal Insufficiency 01/2013
1	Chronic Disease (Chronic Diseases) 01/2013
1	Type 2 Diabetes Mellitus (MODY) 01/2013
1	Human Influenza (Influenza) 05/2010
1	Crystalluria 02/2007
1	Pulmonary Edema 03/2005
1	Heart Failure 03/2005
1	Myocardial Infarction 03/2005
1	Esophagitis 08/2004
1	Hypertension (High Blood Pressure) 05/2004
1	Rheumatoid Arthritis 08/2003
1	Low Back Pain (Lumbago) 08/2003
1	Postmenopausal Osteoporosis 01/2002

Drug/Important Bio-Agent (IBA)

4	rofecoxib (Vioxx)FDA Link 02/2007 - 08/2004
3	LipopolysaccharidesIBA 06/2019 - 09/2015
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2007 - 03/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2006 - 01/2002
2	AdiponectinIBA 01/2022 - 01/2022
2	HMGB1 Protein (HMG1)IBA 06/2019 - 09/2015
2	1- stearoyl- 2- linoleoylphosphatidylcholineIBA 06/2019 - 10/2016
2	Pharmaceutical PreparationsIBA 01/2018 - 08/2004
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 08/2004 - 08/2003
2	Ibuprofen (Motrin)FDA LinkGeneric 08/2004 - 08/2003
1	AdipokinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	ChromatinIBA 01/2022
1	ResveratrolIBA 05/2021
1	3' Untranslated Regions (3' UTR)IBA 09/2020
1	apelin-13 peptideIBA 01/2020
1	LigandsIBA 01/2020
1	Donepezil (Aricept)FDA LinkGeneric 01/2020
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 06/2019
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 06/2019
1	CateninsIBA 11/2018
1	MicroRNAs (MicroRNA)IBA 11/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	bis(3',5')-cyclic diguanylic acidIBA 03/2016
1	turmeric extractIBA 02/2016
1	Adenosine Monophosphate (AMP)IBA 02/2016
1	CurcuminIBA 02/2016
1	Protein Kinases (Protein Kinase)IBA 02/2016
1	AICA ribonucleotide (ZMP)IBA 01/2015
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2013
1	Cystatin CIBA 01/2013
1	CreatinineIBA 01/2013
1	VaccinesIBA 05/2010
1	Amino Acids FDA Link 02/2007
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2004
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2004
1	EtoricoxibIBA 08/2003
1	Diclofenac (SR 38)FDA LinkGeneric 08/2003
1	Naproxen (Naprosyn)FDA LinkGeneric 08/2003
1	Cyclooxygenase InhibitorsIBA 08/2003
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2002

Therapy/Procedure

3	Chemoprevention 02/2007 - 03/2005
1	Skin Transplantation (Skin Grafting) 04/2022
1	Transplantation 07/2021
1	Aftercare (After-Treatment) 01/2015
1	Therapeutics 01/2013